Skip to content

Author

Don J. Diamond

We have 1 of 6 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Phase 2 Evaluation of two GEO-CM04S1 Dose Levels Shows Comparable Safety and Broad Immunogenicity.

BACKGROUND GEO-CM04S1 is a synthetic modified vaccinia Ankara (sMVA)-based SARS-CoV-2 vaccine expressing Spike (S) and Nucleocapsid (N) antigens derived from the ancestral Wuhan-Hu-1 reference strain. This phase 2 study evaluated the safety and immunogenicity of two GEO-CM04S1 dose levels administered as a single boost...

Sandra Ortega-Francisco, Maria Teresa Prudente de Aquino, F. Chiuppesi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.